Table of Contents
- Completion of Cowell Medi Global Innovation Center… Busan Gangseo-gu, Poised to Become a Hub for Dental Implants
- Daewoo Pharmaceutical Invests 5 Billion KRW in Saha-gu Headquarters… Expanding Ophthalmic Pharmaceuticals Production Base
- 'Biohealth', One of the Nine Strategic Industries, Led by Busan City
- Conclusion: Busan is Evolving into a Biohealth Hub City
- Frequently Asked Questions (FAQ)
Completion of Cowell Medi Global Innovation Center… Busan Gangseo-gu, Poised to Become a Hub for Dental Implants
The 'Cowell Medi Global Innovation Center' has been newly completed in the Eco Delta City Urban Advanced Industrial Complex located in Gangseo-gu, Busan, raising expectations for the development of Busan's biohealth industry.
At the completion ceremony held on June 24, more than 150 industry officials, including Busan Mayor Park Hyung-jun and the Gangseo District Office Head, attended to celebrate the growth of the regional high-tech industry.
The newly established Cowell Medi 2nd Factory is a specialized production facility for dental implants equipped with the latest smart factory systems and R&D facilities. Plans are underway to move the headquarters to Busan and develop it as a hub for global exports.
Cowell Medi is the first company in Korea to localize dental implants and is currently exporting products to more than 60 countries, proving its competitiveness in the global market.
Through the newly opened Global Innovation Center, they plan to enhance production capabilities, hire local talent, and operate industrial tour programs to actively promote growth alongside the community.
Daewoo Pharmaceutical Invests 5 Billion KRW in Saha-gu Headquarters… Expanding Ophthalmic Pharmaceuticals Production Base
On June 23, a day before the completion ceremony, good news came from Busan. The local company Daewoo Pharmaceutical announced plans to invest 5 billion KRW to expand its ophthalmic pharmaceuticals production base on its idle land in Saha-gu.
Founded in Busan in 1976, Daewoo Pharmaceutical is a small to medium-sized enterprise that mainly produces over 200 types of specialized pharmaceuticals, including ophthalmic eye drops. The investment will create a new production facility with a total floor area of 6,403㎡ and is expected to hire over 100 new employees. In particular, the production line is expected to expand more than twice compared to the existing one, positively affecting local youth employment and significantly contributing to technology enhancement.
This move by Daewoo Pharmaceutical is expected to bring about significant changes to the local economy and job market.
The city of Busan plans to address the concentration of the pharmaceutical and bio industry in the metropolitan area through Daewoo Pharmaceutical's expansion investment. This is expected to create important opportunities for the development of Busan's bio industry ecosystem.
'Biohealth', One of the Nine Strategic Industries, Led by Busan City
The city of Busan has designated the biohealth industry as one of the nine strategic industries in the "6th Comprehensive Plan for Promoting Strategic Industries" announced in December 2024. This plan serves as an important milestone for changing Busan's economic structure.
The recent investments by Cowell Medi and Daewoo Pharmaceutical are seen as positive examples contributing to realizing this strategy. In particular, the concentrated nurturing of high-value-added fields such as dental medical devices and ophthalmic pharmaceuticals is establishing an effective alternative to the metropolitan-centered industrial structure.
These changes are expected to provide unique new growth drivers for Busan and greatly contribute to revitalizing the local economy.
Optimal Location for Digital Dentistry 'Busan' Enhances Global Competitiveness
Busan is currently establishing itself as a major hub in the domestic dental implant industry. Distinguished companies such as Cowell Medi, Osstem Implant, and Dentium are concentrated here, creating the optimal environment for the advancement of digital dentistry and customized medical technologies.
In addition, an organic cooperation system between local universities and companies has been established, allowing for various programs such as on-site training, talent development, and technology transfer. This cooperation is expected to create a virtuous cycle in the local economy.
Busan Mayor Park Hyung-jun stated, "Our city is actively working to attract the National Dental Research Institute and sees the biohealth industry as a future growth driver." He emphasized, "The recently completed Cowell Medi Center and Daewoo Pharmaceutical's investments will further strengthen Busan's industrial competitiveness."
Conclusion: Busan is Evolving into a Biohealth Hub City
The completion of the Cowell Medi Global Innovation Center located in Gangseo-gu, Busan, and the large-scale investment by Daewoo Pharmaceutical in Saha-gu signify important implications for the regional development strategy centered on the biohealth industry.
A variety of technologies such as dentistry, ophthalmic pharmaceuticals, research and development (R&D), and smart factories are converging to form a self-sustaining ecosystem within the region. As a result, Busan is likely to emerge as a new hub for the bio-industry.
Busan's goal of attracting "over 8 trillion KRW in investments" is not just a figure but a foundation for the advancement of regional industries and sustainable growth. This will serve as an important stepping stone for a bright future for Busan.
#BusanBiohealth, #CowellMedi, #GlobalInnovationCenter, #DentalImplants, #BusanGangseoIndustrialComplex, #EcoDeltaCity, #DaewooPharmaceutical, #SahaInvestment, #50BillionKRWMOU, #BiohealthIndustry, #SmartFactory, #BusanStrategicIndustries, #DentalResearchInstitute, #DigitalDentistry, #LocalEconomicRevitalization, #BusanBioCluster, #BioCompanyAttraction, #R&DCenter, #OphthalmicPharmaceuticals, #EyeDropProduction, #JobCreationInBusan, #IndustryAcademiaCooperation, #BusanInvestmentAttraction, #BusanAdvancedIndustry, #GangseoUrbanHighTechIndustrialComplex, #RelocationOfHeadquartersToBusan, #BiopharmaceuticalCompanies, #BusanIndustrialGrowth, #BusanMayorNews, #BusanFutureIndustry
Frequently Asked Questions (FAQ)
Q. What is the significance of the Cowell Medi Global Innovation Center in Gangseo-gu, Busan?
The Cowell Medi Center is an advanced biohealth facility that aims to establish Gangseo-gu, Busan as a hub for dental implants.
The Cowell Medi Global Innovation Center, completed in the Eco Delta City industrial complex in Gangseo-gu, Busan, is a specialized production facility for dental implants equipped with the latest smart factory and R&D facilities. This center is expected to play a role as a global export hub following the relocation of the headquarters to Busan, contributing to the development of high-tech industries in the region and job creation. It symbolizes an important turning point for the growth and competitiveness of Busan's biohealth industry.
Q. What are Daewoo Pharmaceutical's investment plans for the expansion of its Saha-gu headquarters in Busan?
Daewoo Pharmaceutical will invest 5 billion KRW to expand its ophthalmic pharmaceuticals production base at its Saha-gu headquarters.
Daewoo Pharmaceutical is pursuing the construction of a new factory with an area of 6,403㎡ on its idle land and is expected to create over 100 new jobs. The production capacity is poised to increase more than double the current level, strengthening the production of specialized pharmaceuticals such as ophthalmic eye drops and contributing to the balanced development of the Busan bio-industry. This investment is also expected to positively impact youth employment and enhance technological capabilities in the region.
Q. What is the background for Busan City promoting the biohealth industry as a strategic industry?
Busan City has designated biohealth as one of the nine strategic industries to innovate the local economic structure and address the concentration of industries in the metropolitan area.
Busan City is nurturing biohealth as a core growth driver through the "6th Comprehensive Plan for Promoting Strategic Industries" announced in 2024. By focusing support on high-value-added dental medical devices and ophthalmic pharmaceuticals, as seen in the cases of Cowell Medi and Daewoo Pharmaceutical, it aims to enhance competitiveness, alleviate industrial concentration issues in the metropolitan area, and contribute to local job creation. This is a long-term strategy with the goal of revitalizing Busan's economy and securing new growth drivers.
Q. What are Busan's competitive strengths in the field of digital dentistry?
Busan is home to major domestic dental implant companies, creating an optimal environment for the advancement of digital dentistry.
Renowned companies such as Cowell Medi, Osstem Implant, and Dentium are clustered in Busan, advancing state-of-the-art customized medical technologies. Local universities and industries are actively cooperating to foster talent, facilitate on-site training, and promote technology transfer, showcasing a robust research and industry-academia cooperation system in digital dentistry. Busan is actively working to attract the National Dental Research Institute, aiming to continuously strengthen global competitiveness.
Q. What impact does the development of Busan's biohealth industry have on the local economy?
The nurturing of the biohealth industry promotes the revitalization of Busan's local economy, job creation, and the advancement of high-tech industries.
The completion of the Cowell Medi Global Innovation Center and the large-scale investment by Daewoo Pharmaceutical reinforce the biohealth-centric ecosystem within Busan. By expanding R&D and production based on smart factories and employing specialized talent, it invigorates the local economy, providing a stepping stone for the transformation of the high-tech industry structure. The goal of attracting investments exceeding 8 trillion KRW envisioned by Busan City positions the region for sustainable industrial growth and boosts future competitiveness.